Life Molecular Imaging
  • Home
  • About
    • Our Mission
    • Our History
    • Our Partners
    • Compliance & Code of Conduct
  • Innovation
    • Neuroimaging
    • Cardiovascular Imaging
    • Pharma Collaborations
  • Products
    • Neuraceq®
  • Clinical Trials
    • Advance study
    • Cardiag Study
    • Expanded Access Program
  • Careers
  • News
    • Press Releases
    • Selected Publications
  • Contact
Life Molecular Imaging
  • Home
  • About
    • Our Mission
    • Our History
    • Our Partners
    • Compliance & Code of Conduct
  • Innovation
    • Neuroimaging
    • Cardiovascular Imaging
    • Pharma Collaborations
  • Products
    • Neuraceq®
  • Clinical Trials
    • Advance study
    • Cardiag Study
    • Expanded Access Program
  • Careers
  • News
    • Press Releases
    • Selected Publications
  • Contact
NEWS

Life Molecular Imaging announces presentation of new scientific data at the Alzheimer’s Association International Conference

14 July 2023

LEARN MORE
NEWS

Life Molecular Imaging Applauds FDA’s Full Approval of LEQEMBI® for Alzheimer’s Disease

6 July 2023

LEARN MORE
NEWS

Life Molecular Imaging Announces New Data on Amyloid PET Quantification

14 June 2023

LEARN MORE
NEWS

Life Molecular Imaging Announces Start of Phase 3 Study with [18F]Florbetaben in Cardiac Amyloid Light Chain (AL) Amyloidosis

7 February 2023

LEARN MORE
NEWS

Life Molecular Imaging and Advanced Medical Support Announce a Strategic Partnership for the Production of Florbetaben (18F) at the American University of Beirut Medical Centre, Lebanon

25 January 2023

LEARN MORE
NEWS

Life Molecular Imaging Announces Start of the Phase 3 Histopathology Study “ADvance” for the Tau PET Tracer [18F]PI-2620

17 January 2023

LEARN MORE
NEWS

Life Molecular Imaging and Jubilant Radiopharma announce Neuraceq® availability in Southeast United States

10 January 2023

LEARN MORE
NEWS

Life Molecular Imaging announces presentation of new scientific data at the European Association of Nuclear Medicine annual meeting 2022

14 October 2022

LEARN MORE
NEWS

Statement of Life Molecular Imaging on Eisai and Biogen announcing Positive Topline Results of their Phase 3 Clarity AD Study

28 September 2022

LEARN MORE
NEWS

Life Molecular Imaging and Curium Pharma Announce the Start of Neuraceq® Production at Curium’s Blackrock Clinic in Dublin

29 August 2022

LEARN MORE
  • 1
  • 2
  • 3
  • 4
  • 5